Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Human CXCL10 (IP-10) Recombinant Protein
Click to view available options
Quantity:
25 μg
Description
IP10 (human) Recombinant Protein, RP-8647, from Invitrogen.
The chemokine IP-10 (or CXCL10) is a chemokine made by monocytes, endothelial cells and fibroblasts in response to treatment with IFNgamma. IP-10 functions as a chemoattractant to cells (activated T cells and NK cells) expressing the G protein-coupled receptor, CXCR3. IP-10 plays an important role in Th1 type inflammatory diseases and autoimmune diseases such as, Hashimoto′s thyroiditis, Graves′ disease and Type 1 diabetes mellitus. Recombinant human IP-10 is a non-glycosylated protein, containing 77 amino acids, with a molecular weight of 8.5 kDa. Purity is typically greater than 97% and endotoxin level less than 1 EU/ug. The expected biological activity (ED50) is determined by the ability to chemoattract human T lymphocytes at 5-40ng/mL. The specific activity of this protein is 2x10^5 units/mg. Reconstitute using sterile water at 0.1mg/mL and centrifuge prior to opening vial. Gently pipet solution down the sides of the vial. DO NOT VORTEX sample. Store reconstituted material at -20°C and add 0.1% BSA for additional stability. Amino acid sequence: VPLSRTVRCT CISISNQPVN PRSLEKLEII PASQFCPRVE IIATMKKKGE KRCLNPESKA IKNLLKAVSK EMSKRSP.

Specifications
Specifications
Accession Number | P02778 |
Concentration | 0.1mg/mL |
For Use With (Application) | Control |
Formulation | 0.1%TFA with no preservative |
Gene ID (Entrez) | 3627 |
Molecular Weight (g/mol) | ∽8.5 |
Name | Human CXCL10 |
Quantity | 25 μg |
Source | E. coli |
Storage Requirements | -20°C, Avoid Freeze/Thaw Cycles |
Show More |
in vitro research only
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction